This inventor holds 3 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Mersana Therapeutics, Inc.. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: The Innovative Contributions of Donald A. Bergstrom
Introduction
Donald A. Bergstrom is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies for cancer treatment. With a total of 3 patents to his name, Bergstrom's work has the potential to impact patient care and treatment outcomes.
Latest Patents
Bergstrom's latest patents include innovative compositions and methods for predicting response to NaPi2b-targeted therapy. This disclosure provides reagents and methods for predicting the responsiveness of a patient to NaPi2b-targeted antibody-drug conjugates. Another significant patent focuses on NaPi2b-targeted polymer antibody-drug conjugates and outlines dosing regimens for these targeted therapies in cancer treatment.
Career Highlights
Bergstrom is currently associated with Mersana Therapeutics, Inc., where he continues to advance his research and development efforts. His work at Mersana Therapeutics emphasizes the importance of targeted therapies in improving cancer treatment efficacy.
Collaborations
Throughout his career, Bergstrom has collaborated with talented professionals, including Laura L. Poling and Rebecca Mosher. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Donald A. Bergstrom's contributions to the field of biotechnology and cancer treatment through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in targeted therapies, ultimately benefiting patients in need.